UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in INCY — Incyte Corp
CIK 861177
NEW YORK, NY
Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$145,030,725
-$10,504,166 QoQ
Shares Held
1,540,913
-2.1% QoQ
Ownership
0.771%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 49.100565703579626.ToString("F0")%
Shared 0.ToString("F0")%
None 50.89943429642037.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,812 across 211 Biotechnology names. INCY ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
This page
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $145,030,725 | 1,540,913 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $155,534,891 | 1,574,718 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $127,519,038 | 1,503,585 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $134,201,396 | 1,970,652 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $95,857,665 | 1,583,116 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $106,107,952 | 1,536,238 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $91,182,630 | 1,379,465 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $110,225,035 | 1,818,295 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $68,738,801 | 1,206,579 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $76,463,270 | 1,217,762 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $70,366,974 | 1,218,054 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $72,989,739 | 1,172,526 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $84,738,449 | 1,172,526 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $121,145,365 | 1,508,284 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $128,770,067 | 1,932,324 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $165,073,766 | 2,172,881 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $182,983,356 | 2,303,996 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $98,190,259 | 1,337,742 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $104,304,935 | 1,516,501 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $130,103,673 | 1,546,460 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $122,630,898 | 1,508,932 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $212,766,297 | 2,446,152 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $207,268,885 | 2,309,660 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $321,804,716 | 3,095,169 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $266,810,644 | 3,643,461 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||